Aimei Health Technology Co., Ltd. (NASDAQ:AFJK – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 2,710 shares, a drop of 52.3% from the April 30th total of 5,686 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily trading volume, of 2,016 shares, the days-to-cover ratio is presently 1.3 days.
Aimei Health Technology Trading Up 21.0%
AFJK stock traded up $7.13 during trading on Tuesday, hitting $41.07. 1,937 shares of the company’s stock were exchanged, compared to its average volume of 2,782. The business has a 50-day moving average price of $38.93 and a two-hundred day moving average price of $38.81. The stock has a market capitalization of $130.19 million, a price-to-earnings ratio of 220.83 and a beta of 0.23. Aimei Health Technology has a 52-week low of $6.75 and a 52-week high of $130.37.
Aimei Health Technology (NASDAQ:AFJK – Get Free Report) last posted its earnings results on Monday, May 4th. The company reported $0.02 earnings per share for the quarter.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on Aimei Health Technology
Institutional Investors Weigh In On Aimei Health Technology
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Jane Street Group LLC purchased a new stake in Aimei Health Technology in the fourth quarter valued at approximately $302,000. Dakota Wealth Management purchased a new stake in Aimei Health Technology in the fourth quarter valued at approximately $406,000. Geode Capital Management LLC purchased a new stake in Aimei Health Technology in the fourth quarter valued at approximately $413,000. Clear Street Group Inc. purchased a new stake in Aimei Health Technology in the third quarter valued at approximately $691,000. Finally, Quarry LP lifted its stake in Aimei Health Technology by 6.4% in the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after buying an additional 10,000 shares during the last quarter. Hedge funds and other institutional investors own 45.58% of the company’s stock.
Aimei Health Technology Company Profile
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.
See Also
- Five stocks we like better than Aimei Health Technology
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear CaseāIs a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.
